$Nabriva T_老虎社区_美港股上老虎

2021-06-20

$Nabriva Therapeutics AG(NBRV)$该企业可能创建额外普通股，已经颁布了提案，届时会更新董事权力，会对现股价造成影响。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

慕羽白
2021-06-21
慕羽白
利空

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":164674807,"tweetId":"164674807","gmtCreate":1624204533109,"gmtModify":1624204533109,"author":{"id":3575064196801882,"authorId":3575064196801882,"authorIdStr":"3575064196801882","name":"慕羽白","avatar":"https://static.tigerbbs.com/0d42c98c5adea5142659782b89488269","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.16","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NBRV\">$Nabriva Therapeutics AG(NBRV)$</a>该企业可能创建额外普通股，已经颁布了提案，届时会更新董事权力，会对现股价造成影响。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NBRV\">$Nabriva Therapeutics AG(NBRV)$</a>该企业可能创建额外普通股，已经颁布了提案，届时会更新董事权力，会对现股价造成影响。</p></body></html>","text":"$Nabriva Therapeutics AG(NBRV)$该企业可能创建额外普通股，已经颁布了提案，届时会更新董事权力，会对现股价造成影响。","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/164674807","repostId":0,"isVote":1,"tweetType":1,"viewCount":3661,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NBRV"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":107,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":4915144,"gmtCreate":1624205140102,"gmtModify":1624205140102,"authorId":3575064196801882,"author":{"id":3575064196801882,"authorId":3575064196801882,"name":"慕羽白","avatar":"https://static.tigerbbs.com/0d42c98c5adea5142659782b89488269","vip":1,"currentWearingBadge":{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.16","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":164674807,"type":1,"supId":0,"prevId":0,"content":"利空","text":"利空","html":"利空","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/164674807"}